Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | RANTES | 1297.0 | 55 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | RANTES | 128.5 | 50 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | RANTES | 1058.0 | 65 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | RANTES | 23677.0 | 70 | |
RA1869 | TNF-a | 100 | ng/mL | 1 | RANTES | 23289.0 | 63 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | RANTES | 16132.0 | 87 | |
N2759 | TNF-a | 100 | ng/mL | 1 | RANTES | 24349.5 | 60 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | RANTES | 17974.0 | 47 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | RANTES | 20962.0 | 59 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | RANTES | 22513.0 | 65 | |
N2586 | TNF-a | 100 | ng/mL | 1 | RANTES | 23449.0 | 53 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 32.0 | 49 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 86.0 | 45 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 39.5 | 54 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 255.0 | 60 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 36.0 | 65 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 363.0 | 42 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 46.0 | 42 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 134.5 | 44 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 8175.0 | 51 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 11129.0 | 37 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 7356.0 | 61 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 9141.0 | 51 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 10718.0 | 54 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 11991.0 | 55 |